Le Lézard
Classified in: Health, Science and technology
Subject: SCZ

Fit Minds' Cognitive Coaching Expands its Impact throughout Florida's Gulf Coast Region

TAMPA, Fla., Sept. 25, 2019 /PRNewswire/ -- Fit Minds, a technology-based cognitive stimulation solution offering life-changing, research-backed programs for seniors with Alzheimer's and dementia, expands its foothold across Florida's gulf coast by partnering with 21 senior living communities. Headquartered in Tampa, Fla., Fit Minds is an effective non-pharmacological treatment option for Alzheimer's and other forms of dementia that combines human-to-human, meaningful engagement with a sophisticated cognitive improvement measurement software that is quickly gaining traction across the state of Florida for its results.

Fit Minds, a revolutionary treatment for Alzheimer's and dementia patients, offers life-changing cognitive stimulation therapy to seniors in Illinois and Florida.

President and CEO Janet Knupp brought Canada-based Fit Minds to Tampa in late 2017, following her mother's diagnosis with Lewy Body, a form of dementia causing progressive decline in mental abilities. Knupp, a veteran education CEO with both private equity and not-for-profit experience, sought out a program that went beyond pharmaceutical care. When she began Fit Minds' cognitive stimulation program with her mother, she was astounded by the results.

"I saw the magic," said Knupp, "My mother was herself down to her last day of life. She knew who I was, and who her grandchildren were. She began reading and writing again. The data I was able to collect from her coaching sessions is how we knew when to make the difficult decision to move her from a senior living community to hospice, and she passed two weeks later. She left our world with dignity and an amazing quality of life."

Like Knupp's mother, clients suffering from dementia or Alzheimer's have experienced positive results such as reading again, living independently, remembering family members, and in some Lewy Body cases, even keeping hallucinations at bay for extended periods of time. These results, as well as Fit Mind's unique use of data-collecting software combined with human-to-human coaching is what has attracted many families and assisted living communities to partner with Fit Minds.

The Fit Minds program leverages technology to target five key areas of cognition to develop a customized mental stimulation plan led by a certified coach. Fit Minds' coaches meet regularly with seniors to provide cognitive stimulation lessons, supporting what research tells us about the brain's ability to build resilience and create new neuron pathways to prevent memory loss. Each lesson not only offers meaningful engagement for those with Alzheimer's or dementia, but it also allows family members to stay connected.

"My family and I are grateful to have wonderful coaches work with Mom on a weekly basis," said Fit Minds' client, Christi Harrington. "We especially enjoy the monthly assessment reports that show us her engagement with various subjects, and love to see how the Fit Minds staff always puts a smile on her face." 

The innovative program originated in Canada, where it is actively used in 25 percent of senior living communities. The UK's National Institute for Health and Care Excellence (NICE) mandates that CST therapy be offered to dementia patients upon first diagnosis.

"Fit Minds is an amazing program delivering real results that matter for the client, family and physicians overseeing the client's care," said Lead Senior Living Advisor at Allegro Hyde Park, Suzi Moreland. "I have seen firsthand the life-changing impact this program has on people."

Fit Minds is currently available in 21 senior living communities in Florida, with investor-backed plans for rapid growth. It offers three primary programs: one-on-one coaching, large group sessions, and community subscriptions, allowing seniors to receive CST coaching from Fit Minds at home or on site at a senior living community.

Scott C. Smith, Fit Minds board chair, added, "A small group of us invested in Fit Minds because of our high confidence in Janet's outstanding leadership, and her vision for Fit Minds to improve the quality of life for the millions of seniors and their families who face the challenges of onset dementia."

An estimated 5.8 million Americans live with Alzheimer's disease and by 2050 it will rise to nearly 40 million. "I want Fit Minds to be a game changer for seniors and for it to become the norm in Florida," said Knupp. "Dementia changes relationships; it does not end them."

About Fit Minds
Fit Minds offers an enhanced quality of life for seniors with dementia and Alzheimer's through a customized, research-backed cognitive stimulation therapy program that combines human-to-human, meaningful engagement with a sophisticated cognitive improvement measurement software. The company offers three core programs: one-on-one cognitive coaching led by a Personal Trainer for the Mindtm, premier group sessions led by Fit Minds certified coaches, and subscription group content led by senior living professionals.

Bri Wagner
(813) 258-5858 x. 2260

SOURCE Fit Minds

These press releases may also interest you

at 14:30
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Baxter International Inc. between February 21, 2019 and October 23, 2019, inclusive (the "Class Period") of the important January 24, 2020 lead plaintiff...

at 14:05
Kite, a Gilead Company , today announced new data from the ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) in adult patients with refractory large B-cell lymphoma. These results included updated overall survival data from the pivotal phase 2...

at 14:05
bluebird bio, Inc. announced new data from its ongoing Phase 1/2 HGB-206 study of investigational LentiGlobintm gene therapy for sickle cell disease (SCD), including additional patients treated in the study and updated data for those previously...

at 14:05
Aleta Biotherapeutics, a privately held immunotherapy company focused on transforming cellular therapeutics to allow a broad spectrum of cancer indications to be targeted, today presented in vitro and in vivo results demonstrating that Aleta's novel...

at 14:05
Seattle Genetics, Inc. today announced updated and long-term follow-up analyses from two clinical trials evaluating ADCETRIS (brentuximab vedotin) and OPDIVO® (nivolumab) in frontline Hodgkin lymphoma (HL) patients aged 60 years and older and in...

at 14:05
Bristol-Myers Squibb Company today announced the pivotal study of lisocabtagene maraleucel (liso-cel) an investigational CD19-directed CAR T-cell therapy with a defined composition of purified CD8+ and CD4+ CAR T cells in relapsed/refractory large...

News published on 25 september 2019 at 11:25 and distributed by: